Navigation Links
Sinovac Reports Unaudited Second Quarter 2011 Financial Results
Date:8/12/2011

We anticipate that the Certificate of Approval for Anflu will be granted in the coming months as we prepare for the commercial launch of the vaccine in Mexico."

Dr. Yin concluded, "We are encouraged by the second quarter sales activity and public market orders received in recent months.  We believe that the ongoing execution of our revised sales strategy and seasonal flu vaccine sales that typically take place in the second half of the year will enable continued revenue growth. We look forward to updating you on the continued progress across our vaccine development pipeline."

Financial Review for the Second Quarter Ended June 30, 2011 Sales for the second quarter 2011 were $15.7 million, up 52.5% from $10.3 million for the second quarter of 2010. During the second quarter 2011, Sinovac recorded $7.7 million in pandemic influenza vaccine sales on prior year order.

Sinovac's sales breakdown by product was as follows.Three months ended June 30,2011

2010SalesHepatitis vaccines

$8,097,941

$8,676,883Influenza vaccines

7,558,158

1,586,823Total

$ 15,656,099

$ 10,263,706Gross profit for the second quarter 2011 was $10.8 million, with a gross margin of 68.8%, compared to $8.5 million and a gross margin of 82.7% for the same period of 2010.  After deducting depreciation of land use rights and amortization of licenses and permits, the gross margin was 67.9% and 81.7% for the second quarter of 2011 and 2010, respectively. The gross profit margin was adversely affected by the revenue recognition in the second quarter 2011 of the prior pandemic flu vaccine order that had a lower gross margin than other vaccine products.

Selling, general and administrative expenses for the second quarter 2011 were $5.0 million, compared to $4.0 million in the same period of 2010. SG&A expenses as a percentage of second quarter 2011 sales were 31.8%, compared to 38.9% during the second quarter of the pr
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Sinovac Announces Management Changes
2. Sinovac Holds 2011 Annual Shareholders Meeting
3. Sinovac Appoints Kenneth Lee to Board of Directors
4. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
5. Sinovac Reports Unaudited First Quarter 2011 Financial Results
6. Sinovac Presents at Two Investor Conferences in May 2011
7. Sinovac Files Annual Report on Form 20-F
8. Sinovac Participates in UBS Greater China Healthcare Corporate Day
9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
10. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
11. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 Research and Markets ... Breast Cancer Market 2014-2018" report to their offering. ... uncontrolled growth of cancerous cells in the breast tissue. ... breast cancer is rare. Histologically, breast cancer can be ... other undifferentiated carcinoma. Ductal carcinoma is the form of ...
(Date:9/17/2014)... Switzerland , September 17, 2014 ... is proud to congratulate Biocartis commitment in shipping ... is a long-time investor in Biocartis as part ... Biocartis, fully automated, real-time PCR based molecular ... and easy access to clinical molecular diagnostic information, ...
(Date:9/16/2014)... Massachusetts , 17. September 2014 ... HOLX ), hat heute die ... zur präanalytischen Probenverarbeitung, in Europa bekannt ... gekennzeichnete, vollautomatisierte Universalplattform zur Vereinfachung der ... dass ineffiziente und fehlerbehaftete Arbeitsschritte bei ...
Breaking Medicine Technology:Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 2Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 3Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3
... KARLSRUHE, Germany, March 4, 2011 The High Court of ... favor of AmniSure® International, LLC in its dispute with the ... Court,s ruling that the patent associated with Medix,s ActimPROM test ... inventive step. Medix is expected to pay AmniSure® an undisclosed ...
... -- Bacterin International Holdings, Inc. (OTC Bulletin Board: ... revolutionary bone graft material and anti-infective coatings for medical applications, ... listing on the NYSE Amex and has chosen Knight Capital ... stock will commence trading on the NYSE Amex on Monday, ...
Cached Medicine Technology:German High Court Rules in Favor of AmniSure® as New European Guidelines Published 2Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex 2Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex 3
(Date:9/17/2014)... Calif. (PRWEB) September 17, 2014 ... monthly interruptions, giving girls of all ages an ... wellness company founded by women, for women, announces ... Uninterrupted® (http://GirlU.com) to relieve the symptoms ... bloating and irritability. , As a lifelong ...
(Date:9/17/2014)... 17, 2014 In a new video ... William Groff, an expert on the condition known as PPP, ... penile papules , or PPP, is a condition that affects ... men may be affected as well. The condition is characterized ... , “While PPP is not a sexually transmitted disease and ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A raucous ... Disease come together to form author Nancy Chovancek’s laughter-filled ... book is a collection of short stories that prove ... on fun. With a positive message of empowerment and ... Chovancek is a proven author with two books under ...
(Date:9/17/2014)... GA (PRWEB) September 17, 2014 ... District (DHCHD) has implemented its CollaborNet™ Health ... exchange of patients’ health information between Coon Memorial ... Texas, and physicians in the community. , ... application to enable electronic referrals by physicians to ...
(Date:9/17/2014)... Seattle, Wa (PRWEB) September 17, 2014 ... published by the Telegraph in August 2014, scientists made ... cure for diabetes, but still failed. The article indicates ... , Despite this existing fact, there are many forward-thinking ... for diabetes treatment in a natural way. Dr. Kenneth ...
Breaking Medicine News(10 mins):Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 2Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 3Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2
... 5 seek any assistance, MORAGA, Calif., Oct. 9 ... common disorders, it is regularly under diagnosed by,medical professionals., ... -- muscle tension,headache, nausea, fatigue, or trembling -- before ... during times of stress such as a,divorce, job change ...
... Results of a multicenter study led by Johns Hopkins ... babies with hydrocortisone, a steroid believed to fight inflammation ... treatment offers little or no benefit and that low ... levels, on the other hand, appeared to increase the ...
... New Report Shows Only 17% of Employers Offer Vision Benefits, ... have taken center stage in the upcoming election, worries about,the ... minds of most,Americans. For the 120 million Americans with vision ... value on maintaining healthy vision,the lack of vision coverage is ...
... Generations agrees to sell patents to Life Spine, ... firm Life Spine, Inc. announced today that it has ... LLC. Terms of,the transaction were not disclosed., According ... property expansion is critical. "The core of the spine ...
... Oct. 8 The Hain Celestial,Group, Inc. (Nasdaq: ... food and personal,care products company, today announced that ... to make a presentation regarding the,Company on Wednesday, ... Natural Boston Conference., (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/NYTH131 ...
... Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) ... has completed its previously announced debenture financing ... Midsummer,Investment, Ltd. The gross proceeds of the ... general corporate purposes., "We are very ...
Cached Medicine News:Health News:40 Million Americans Endure Anxiety Everyday 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 2Health News:Steroid treatment offers no benefit in preemies, Hopkins Children's study suggests 3Health News:Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage 2Health News:Americans Place High Value on Eyesight, Yet Many Still Lack Vision Coverage 3Health News:Hain Celestial to Present at Canaccord Adams Healthy Living Naturally Boston Conference on October 15, 2008 2Health News:PreMD Inc. Completes Secured Debenture Financing 2
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
This true 8-bit integrated and cooled imaging system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lightin...
... range of Platelet aggregometers allows to ... particular needs. Single, dual and four ... recorder outputs or digital computer outputs. ... aggregometers, which measure platelet aggregation in ...
Medicine Products: